Cotargeting of Bcl-2 and Mcl-1 shows promising antileukemic activity against AML cells including those with acquired cytarabine resistance.

Liu F, Zhao Q, Su Y, Lv J, Gai Y, Liu S, Lin H, Wang Y, Wang G
Exp Hematol. 2022 Jan;105:39-49. doi: 10.1016/j.exphem.2021.10.006. Epub 2021 Nov 9. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.